Vanda Pharmaceuticals | Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Acadia Pharmaceuticals USD 21.65M 913K 2025-09
Agios Pharmaceuticals USD 1.68M 22K 2025-09
Akebia Therapeutics USD 8.13M 2.41M 2025-03
Alnylam Pharmaceuticals USD 200.15M 57.2M 2025-09
Anika Therapeutics USD 11.49M 35.48M 2025-03
AstraZeneca USD 3.27B 471M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Halozyme Therapeutics USD 73M 8.88M 2025-09
Heron Therapeutics USD 9.46M 1.61M 2024-09
Insmed USD 30.9M 1.56M 2025-09
J&J USD 7.97B 689M 2025-12
Lexicon Pharmaceuticals USD 17.81M 3.41M 2024-06
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
Merck USD 3.32B 531M 2025-12
Minerva Neurosciences 386K 31K 2024-06
Moderna USD 207M 88M 2025-09
Novartis USD 3.54B 216M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 23.32M 7.83M 2025-09
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 4.29B 421M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Ultragenyx Pharmaceutical USD 27.99M 4.99M 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Veracyte USD 41.21M 196K 2025-09


Vanda Pharmaceuticals Koszty Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.